US Broker Ratings

Denali Therapeutics Inc. (DNLI) Stock Analysis: Exploring a Potential 130% Upside in Biotechnology

Denali Therapeutics Inc. (NASDAQ: DNLI), a notable player in the biotechnology sector, is capturing investor attention with its promising pipeline of therapeutics targeting neurodegenerative and lysosomal storage diseases. Headquartered in..

Alvotech (ALVO) Stock Analysis: A Biotech Pioneer with a 60.5% Upside Potential

Alvotech (ALVO), a Luxembourg-based biotech company specializing in biosimilar medicines, is capturing attention in the healthcare investment arena. With a market capitalization of $3.38 billion, Alvotech stands out as a..

Arrowhead Pharmaceuticals, Inc. (ARWR): Biotechnology Stock with a Potential 171% Upside

Investors eyeing opportunities in the biotechnology sector may want to pay close attention to Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR). With a compelling potential upside of 171.34%, this company stands out..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A 50% Potential Upside in the Thriving Mental Health Sector

LifeStance Health Group, Inc. (LFST), a burgeoning player in the healthcare sector, is capturing investor attention with its promising potential upside of 50.63%. As a key provider of outpatient mental..

CG Oncology, Inc. (CGON) Stock Analysis: A Potential 125% Upside in Biotech Sector

Investors with a keen eye on the biotechnology sector may find CG Oncology, Inc. (NASDAQ: CGON) an intriguing prospect. With its market capitalization at $2.03 billion and a striking potential..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotech Innovator with 69.69% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK), a prominent player in the biotechnology sector, is making waves among investors with its promising drug pipeline and substantial potential upside. Headquartered in Cambridge,..

Mirum Pharmaceuticals, Inc. (MIRM): Investor Outlook on This Promising Biotechnology Stock with 49% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the biopharmaceutical sector, particularly among investors looking for promising opportunities in the biotechnology industry. With a market capitalization of $2.28 billion,..

Ardent Health Partners, Inc. (ARDT) Stock Analysis: Unlocking a Potential 41% Upside

Ardent Health Partners, Inc. (ARDT), a key player in the U.S. healthcare sector, is capturing investor attention with its robust potential upside. As a prominent provider of medical care facilities,..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unveiling a 148% Potential Upside Amidst Promising Pipeline

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands out in the biotech sector with a compelling investment thesis driven by its focus on rare and ultra-rare genetic diseases. With a market cap..

Organon & Co. (OGN) Stock Analysis: Tapping into a 51.35% Potential Upside Amidst Mixed Performance Indicators

For investors looking at the healthcare sector, Organon & Co. (NYSE: OGN) presents a fascinating case study. With a current market capitalization of $2.4 billion, this pharmaceutical company is navigating..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Exploring Growth Amidst 133.7% Revenue Increase

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) is rapidly gaining attention in the biotechnology sector, driven by an impressive 133.7% revenue growth in the past year. Based in Stamford, Connecticut, this commercial-stage..

ICU Medical, Inc. (ICUI) Stock Analysis: 42.64% Potential Upside Awaits Investors

ICU Medical, Inc. (NASDAQ: ICUI) stands as a formidable player in the healthcare sector, focusing on the development and manufacture of essential medical devices used globally in infusion therapy, vascular..

NewAmsterdam Pharma (NAMS) Stock Analysis: 126% Potential Upside Captivates Investors

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a key player in the biotechnology sector, is garnering significant attention from investors due to its impressive potential upside of 126.49%. Based in the..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Unpacking a 245% Potential Upside in Biotech

Viking Therapeutics, Inc. (NASDAQ: VKTX), a promising player in the biotechnology sector, is drawing significant attention from investors with its robust pipeline of clinical-stage therapeutics. Headquartered in San Diego, California,..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Challenges in the Healthcare Sector

Envista Holdings Corporation (NYSE: NVST) presents a unique case for investors seeking opportunities within the healthcare sector, specifically in the medical instruments and supplies industry. With a market capitalization of..

Immunovant, Inc. (IMVT) Stock Analysis: Exploring a Potential 184% Upside in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT), a clinical-stage biopharmaceutical company specializing in monoclonal antibodies for autoimmune diseases, has recently caught the eye of investors with a notable potential upside of 184.03%. As..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Analysts See Nearly 37% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a dynamic player in the biotechnology sector, has been capturing investor attention with its promising pipeline and potential for significant stock appreciation. Headquartered in Newark,..

PROCEPT BioRobotics (PRCT) Stock Analysis: Unpacking a 32.68% Upside Potential

For investors keen on the healthcare sector, particularly in the realm of medical devices, PROCEPT BioRobotics Corporation (NASDAQ: PRCT) presents a compelling opportunity. This San Jose-based company is making waves..

Zai Lab Limited (ZLAB) Stock Analysis: Unpacking a 77% Potential Upside in Biotech Investment

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, has been drawing significant attention from investors due to its promising pipeline and strategic alliances. As a company..

Amedisys Inc (AMED) Stock Analysis: Navigating Growth in Healthcare with a 2.51% Potential Upside

Amedisys Inc (NASDAQ: AMED), a prominent player in the healthcare sector, is making waves with its specialized services in home health, hospice, and high acuity care. With a current market..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds